Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays

Intervirology. 2010;53(3):183-7. doi: 10.1159/000289342. Epub 2010 Mar 3.

Abstract

Hepatitis B surface antigen (HBsAg) is considered the best marker for the diagnosis of hepatitis B virus (HBV) infection. Mutations of the s gene involving amino acid substitutions within the a determinant could affect the sensitivity of diagnostic tests. In the present study, HBsAg mutants were detected in 3 immunocompromised patients, previously found to be HBsAg negative and anti-HBs positive. All patients had high levels of HBV-DNA, whereas HBsAg tests gave discordant results. Immunosuppression can cause viral reactivation of occult HBV infection in these patients and favour the selection of HBsAg a determinant mutants.

Publication types

  • Case Reports
  • Evaluation Study

MeSH terms

  • Aged
  • DNA, Viral / blood
  • Female
  • Hepatitis B / diagnosis*
  • Hepatitis B Antibodies / blood
  • Hepatitis B Surface Antigens / blood*
  • Hepatitis B Surface Antigens / genetics*
  • Hepatitis B virus / genetics*
  • Hepatitis B virus / isolation & purification*
  • Humans
  • Immunoassay
  • Immunocompromised Host
  • Male
  • Middle Aged
  • Mutation, Missense*
  • Sensitivity and Specificity

Substances

  • DNA, Viral
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens